Robert Nelsen

target

INSITRO

bidder

Alexandria Venture Investments

£116m

38 dealmakers

target

GRAIL

bidder

Illumina

£6,190m

107 dealmakers

target

National Resilience

bidder

8VC

£562m

13 dealmakers

target

Scineuro Pharmaceuticals

bidder

Lilly Asia Ventures

£75m

7 dealmakers

target

Prime Medicine

bidder

T. Rowe Price Group

£227m

17 dealmakers

target

BIT.BIO

bidder

Charles River Laboratories International

£76m

8 dealmakers

target

Generate Biomedicines

bidder

Flagship Pioneering

£274m

11 dealmakers

target

Nutcracker Therapeutics

bidder

Arch Venture Partners

£128m

4 dealmakers

target

Be Bio

bidder

Atlas Venture

£99m

10 dealmakers

target

VIZGEN

bidder

Sofina

£67m

9 dealmakers

target

National Resilience

bidder

Arch Venture Partners

£500m

9 dealmakers

target

SIRONAX

bidder

Temasek Holdings

£163m

15 dealmakers

target

Neumora Therapeutics

bidder

Arch Venture Partners

£101m

13 dealmakers

target

HOMEWARD

bidder

Glen Tullman

£40m

4 dealmakers

target

Rippl Care

bidder

Arch Venture Partners

£29m

7 dealmakers

target

VILYA

bidder

Arch Venture Partners

£42m

2 dealmakers

target

Rapport Therapeutics

bidder

Third Rock Ventures

£83m

6 dealmakers

target

Boundless Bio

bidder

Leaps By Bayer

£80m

16 dealmakers

target

Chroma Medicine

bidder

Arch Venture Partners

£111m

18 dealmakers

target

Generate Biomedicines

bidder

Mirae Asset Financial Group

£218m

17 dealmakers

target

City Therapeutics

bidder

REGENERON

£103m

5 dealmakers